UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Young Woman with Unexplained Neutropenia and Neutrophils with Bilobed Nuclei: Marrow Findings

Case reports in hematology, 2023-09, Vol.2023, p.1-4

2023

Volltextzugriff (PDF)

Ayurvedic Remedy for Diabetes as a Cause of Lead Poisoning: A Case Report

The American journal of medicine, 2012-10, Vol.125 (10), p.e3-e4

2012

Volltextzugriff (PDF)

A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4169-4181

2022

Volltextzugriff (PDF)

Improving LDCT screening rates within a large multidisciplinary community based practice using integrated ACR accredited imaging centers

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13582-e13582

2024

Volltextzugriff (PDF)

Utilization of liquid biopsy in a large community oncology practice

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19150-e19150

2020

Volltextzugriff (PDF)

An Unusual Initial Manifestation of Acute Leukemia

The American journal of medicine, 2012-12, Vol.125 (12), p.1173-1174

2012

Volltextzugriff (PDF)

Is pylorospasm a cause of delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy?

Annals of surgical oncology, 2005-03, Vol.12 (3), p.222-227

2005

Volltextzugriff (PDF)

Implementation of 3 month therapy for stage III colon cancer in a large community practice

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15653-e15653

2023

Volltextzugriff (PDF)

The adoption of relugolix for treatment of prostate cancer (PCa) in a large community medical oncology practice

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e13541-e13541

2022

Volltextzugriff (PDF)

A Single Center Retrospective Analysis of Adherence to Molecular Monitoring Guidelines in Patients with Chronic Myeloid Leukemia

Blood, 2016-12, Vol.128 (22), p.2365-2365

2016

Volltextzugriff (PDF)

Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes

The oncologist (Dayton, Ohio), 2024-06, Vol.29 (6), p.534-542

2024

Volltextzugriff (PDF)

Clinical value of timely targeted therapy (TT) for patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADO)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6507-6507

2023

Volltextzugriff (PDF)

Evolution of biomarker testing in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC) in U.S. community practices

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18778-e18778

2022

Volltextzugriff (PDF)

Oral SM-88 plus MPS, an effective yet less toxic treatment option in second-line advanced pancreatic cancer? Final phase II/III study results

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.585-585

2022

Volltextzugriff (PDF)

NGS testing patterns in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC): OneOncology (OO) sites compared to Flatiron Health Nationwide (NAT)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.288-288

2021

Volltextzugriff (PDF)

Biomarker testing patterns and actionability in advanced non-small cell lung cancer (aNSCLC) at OneOncology (OneOnc)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.287-287

2021

Volltextzugriff (PDF)

Heparin-Induced Thrombocytopenia Antibody Testing and Its Cost Effectiveness: Taking a Financial HIT

Blood, 2016-12, Vol.128 (22), p.2343-2343

2016

Volltextzugriff (PDF)

Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA

Future oncology (London, England), 2023-06, Vol.19 (20), p.1397-1414

2023

Volltextzugriff (PDF)

A single-center analysis of initial imaging in multiple myeloma (MM)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18554-e18554

2012

Volltextzugriff (PDF)

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

The Lancet. Haematology, 2022-06, Vol.9 (6), p.e403-e414

2022

Volltextzugriff (PDF)

Abstract 2267: Biomarker testing and treatment (tx) patterns in a large community oncology network

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2267-2267

2022

Volltextzugriff (PDF)

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Cancer, 2002-01, Vol.94 (1), p.25-36

2002

Volltextzugriff (PDF)

Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis

Hematology (Luxembourg), 2008-10, Vol.13 (5), p.282-285

2008

Volltextzugriff (PDF)

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient

Journal of neuro-oncology, 2012, Vol.106 (2), p.427-429

2012

Volltextzugriff (PDF)

Pulmonary embolism diagnosed on computed tomography contrast angiography despite negative venous Doppler ultrasound after spinal surgery

Journal of spinal disorders & techniques, 2011-08, Vol.24 (6), p.358-362

2011

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(34)
Berichte
(1)

Sprache

Englisch
(35)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(18)
Male
(12)
Middle Aged
(12)
Oncology
(10)
Aged
(8)
Female
(8)
Adult
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Aged, 80 And Over
(4)
General & Internal Medicine
(4)
Hematologic And Hematopoietic Diseases
(4)
Hematology
(4)
Medicine, General & Internal
(4)
Chemotherapy
(3)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(3)
Adenocarcinoma
(2)
Antineoplastic Agents
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Young Woman with Unexplained Neutropenia and Neutrophils with Bilobed Nuclei: Marrow Findings

Ayurvedic Remedy for Diabetes as a Cause of Lead Poisoning: A Case Report

A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond

Improving LDCT screening rates within a large multidisciplinary community based practice using integrated ACR accredited imaging centers

Utilization of liquid biopsy in a large community oncology practice

An Unusual Initial Manifestation of Acute Leukemia

Is pylorospasm a cause of delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy?

Implementation of 3 month therapy for stage III colon cancer in a large community practice

The adoption of relugolix for treatment of prostate cancer (PCa) in a large community medical oncology practice

A Single Center Retrospective Analysis of Adherence to Molecular Monitoring Guidelines in Patients with Chronic Myeloid Leukemia

Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes

Clinical value of timely targeted therapy (TT) for patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADO)

Evolution of biomarker testing in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC) in U.S. community practices

Oral SM-88 plus MPS, an effective yet less toxic treatment option in second-line advanced pancreatic cancer? Final phase II/III study results

NGS testing patterns in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC): OneOncology (OO) sites compared to Flatiron Health Nationwide (NAT)

Biomarker testing patterns and actionability in advanced non-small cell lung cancer (aNSCLC) at OneOncology (OneOnc)

Heparin-Induced Thrombocytopenia Antibody Testing and Its Cost Effectiveness: Taking a Financial HIT

Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA

A single-center analysis of initial imaging in multiple myeloma (MM)

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Abstract 2267: Biomarker testing and treatment (tx) patterns in a large community oncology network

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient

Pulmonary embolism diagnosed on computed tomography contrast angiography despite negative venous Doppler ultrasound after spinal surgery

Suchergebnisse filtern